实现更个性化的乳腺癌风险评估:多基因风险评分
Daad Sarkis-Tannous1, Roxanne B Sukol, Erika Sullivan
1At the time this article was written, Daad Sarkis-Tannous, Roxanne B. Sukol, and Erika Sullivan were medical breast specialists at the Cleveland (Ohio) Clinic. Dr. Sukol is now retired. The authors have disclosed no potential conflicts of interest, financial or otherwise.
JAAPA : official journal of the American Academy of Physician Assistants
|September 26, 2023
概括
本文澄清了为医疗保健提供者进行乳腺癌风险评估的内容. 它引入了个性化管理的多基因风险评分,以帮助平均和高风险女性的临床决策.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 预防医学 预防医学
背景情况:
- 医疗保健提供者在准确评估和管理乳腺癌风险方面面临挑战.
- 平均和高风险的妇女需要关于查和预防策略的指导.
- 高风险患者对遗传突变状态的认识较低,使管理复杂化.
研究的目的:
- 帮助临床医生分层分层乳腺癌风险.
- 讨论多基因风险评分对于个性化风险管理的有用性.
- 为乳腺癌预防和查的决策提供信息.
主要方法:
- 审查目前的乳腺癌风险评估策略.
- 讨论基因检测和像MRI这样的先进成像技术.
- 解释多基因风险评分 (PRS) 技术及其应用.
主要成果:
- 多基因风险评分为个性化乳腺癌风险评估提供了一种新的基因组方法.
- 公共公共服务可以改善识别受益于加强查或预防措施的个人.
- 加强风险分层可以导致更为定制和有效的患者管理计划.
结论:
- 准确的乳腺癌风险评估对于有效的患者护理至关重要.
- 多基因风险评分代表了个性化瘤学的重大进步.
- 将PRS整合到临床实践中有可能优化乳腺癌查和预防策略.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Polygenic Traits
66.0K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.0K
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
145
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
Relative Risk
208
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
208


